Other Income, mainly grant income, increased to EUR 1.7M (2023: EUR 0.5M). In 2024, the Company successfully negotiated an amendment with the European Innovation Council and was able to secure ...
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology ...
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, ...
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, ...
Investigational ARC-BCI ® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilities ARC-BCI is the world’s first and most ...
First-in-Human Use of the ARC-IM™ Lead New Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending and Issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results